Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RANITIDINE vs RAVULIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RANITIDINE vs RAVULIZUMAB: Safety Overview

Metric RANITIDINE RAVULIZUMAB
Total FAERS Reports 418,307 118
Deaths Reported 26,824 11
Death Rate 6.4% 9.3%
Hospitalizations 7,673 89
Average Patient Age 57.3 yrs 48.4 yrs
% Female Patients 46.4% 56.3%
FDA Approval Date Apr 1, 2004 N/A
Manufacturer Granules India Ltd Alexion Pharmaceuticals Inc.
Route ORAL INTRAVENOUS
Marketing Status Discontinued N/A